52 filings
Page 3 of 3
8-K
by0o5b vytyc5qu6js
11 May 21
Results of Operations and Financial Condition
7:57am
8-K
7ohlqequxep 5tzeb
17 Feb 21
Royalty Pharma Reports Q4 2020 and Full-year Results
7:16am
8-K
91qf7by8ysb5
3 Feb 21
Other Events
8:22am
8-K
lw5mbaz7o0wdkyx
10 Nov 20
Royalty Pharma Reports Third Quarter 2020 Results
5:16pm
8-K
19bb3x5dagv4geikifl
5 Nov 20
Entry into a Material Definitive Agreement
4:40pm
8-K
kpwtkmcd
2 Sep 20
Royalty Pharma Announces Closing of $6.0 Billion Senior Unsecured Notes
5:26pm
8-K
qrtodod
19 Aug 20
Royalty Pharma Announces Launch of Senior Notes Offering
9:13am
8-K
0det0vow
12 Aug 20
Royalty Pharma Reports Second Quarter 2020 Results
7:33am
8-K/A
3r7m3fchl7 bl4s
3 Aug 20
Departure of Directors or Certain Officers
4:52pm
8-K
g5vjkqp8 1y4r87p6b3
3 Aug 20
Royalty Pharma Appoints Henry a. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors
4:49pm
8-K
m79g46yo8hqcmlzi
14 Jul 20
Pre-quarterly Results Communication
5:04pm
8-K
p9r92o ke79r5a
19 Jun 20
Entry into a Material Definitive Agreement
4:39pm